Mylan loses lawsuit against Sun Pharma over cholesterol drug patents

Ashurst 2019-01-31 7:30 pm By Miklos Bolza | Sydney

Please login to bookmark

Generic drug maker Sun Pharma has emerged victorious in a lawsuit brought against it by Mylan relating to Sun’s plans to launch a generic version of cholesterol drug fenofibrate.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au